SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-078230
Filing Date
2011-03-25
Accepted
2011-03-25 17:04:27
Documents
5
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ON FORM 10-K d10k.htm 10-K 916444
2 CONSENT OF ODENBERG, ULLAKKO, MURANISHI & CO., LLP dex231.htm EX-23.1 1484
3 CERTIFICATION OF THE PRINCIPAL EXEC AND FIN OFFICER PURSUANT TO RULE 13(A)-14(A) dex311.htm EX-31.1 8449
4 CERTIFICATE OF THE PRINCIPAL EXEC AND FIN OFFICER PURSUANT TO 18 U.S. 1350 dex321.htm EX-32.1 3595
5 GRAPHIC g167711g80j10.jpg GRAPHIC 39612
  Complete submission text file 0001193125-11-078230.txt   985748
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27436 | Film No.: 11713125
SIC: 2836 Biological Products, (No Diagnostic Substances)